BETMIGA 50 MG 30 TAB

Betmiga is a medicine containing the active substance mirabegron. Prolonged-release’ means that mirabegron is released slowly from the tablet over a few hours. Betmiga is used in adults with overactive bladder syndrome. It is used to treat certain symptoms of the condition: urgency (sudden urge to urinate), increased urinary frequency (the need to urinate frequently) and urge incontinence (involuntary leakage of urine from the bladder when a sudden strong need to urinate is felt).

How to use? 

The recommended dose of Betmiga is 50 mg once a day. In patients who have reduced kidney or liver function, the doctor may need to prescribe a lower dose.